• Taken together, these findings suggest that DMF, through the activation of Nrf2, has the potential to serve as a therapeutic target for preventing epileptogenesis and modifying epilepsy. (biomedcentral.com)
  • We propose that various shared mechanisms of stress and epilepsy present multiple avenues for the development of new symptomatic and preventative treatments, including disease modifying therapies aimed at reducing epileptogenesis. (bvsalud.org)
  • Epileptogenesis has been described in remote brain regions without any detectable lesions, giving rise to dual epileptogenic foci. (medscape.com)